Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants

被引:2
|
作者
Mischoulon, D. [1 ]
Hylek, L. [1 ]
Yeung, A. S. [1 ]
Clain, A. J. [1 ]
Baer, L. [1 ]
Cusin, C. [1 ]
Ionescu, D. F. [1 ]
Alpert, J. E. [1 ]
Soskin, D. P. [1 ]
Fava, M. [1 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Depress Clin & Res Program, Boston, MA 02115 USA
关键词
D O I
10.1016/j.jad.2017.10.040
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:198 / 198
页数:1
相关论文
共 50 条
  • [1] Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants
    Mischoulon, David
    Hyek, Lindsay
    Yeung, Albert S.
    Clain, Alisabet J.
    Baer, Lee
    Cusin, Cristina
    Ionescu, Dawn Flosnik
    Alpert, Jonathan E.
    Soskinl, David P.
    Faval, Maurizio
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2017, 208 : 6 - 14
  • [2] RETRACTED ARTICLE: The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
    Mahmoud S. Abdallah
    Esraa M. Mosalam
    Abdel-Aziz A. Zidan
    Khaled S. Elattar
    Shimaa A. Zaki
    Ahmed N. Ramadan
    Abla M. Ebeid
    [J]. Neurotherapeutics, 2020, 17 : 1897 - 1906
  • [3] The Phosphodiesterase Inhibitor Pentoxifylline as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
    El-Haggar, Sahar Mohamed
    Eissa, Mai AbdelRaouf
    Mostafa, Tarek Mohammed
    El-Attar, Khaled Sabry
    Abdallah, Mahmoud Samy
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2018, 87 (06) : 331 - 339
  • [4] Retraction Note: The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
    Mahmoud S. Abdallah
    Esraa M. Mosalam
    Abdel-Aziz A. Zidan
    Khaled S. Elattar
    Shimaa A. Zaki
    Ahmed N. Ramadan
    Abla M. Ebeid
    [J]. Neurotherapeutics, 2022, 19 : 1687 - 1687
  • [5] BLAME REBALANCE FMRI FEEDBACK PROOF-OF-CONCEPT TRIAL IN MAJOR DEPRESSIVE DISORDER
    Zahn, R.
    Weingartner, J.
    Basilio, R.
    Bado, P.
    Mattos, P.
    de Oliveira-Souza R, Sato J.
    Fontenelle, L. F.
    Moll, J.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (08): : E25 - E25
  • [6] Blame rebalance FMRI feedback proof-of-concept trial in major depressive disorder
    Zahn, R.
    Weingartner, J.
    Basilio, R.
    Bado, P.
    Mattos, P.
    Sato, J.
    de Oliveira-Souza, R.
    Fontenelle, L. F.
    Moll, J.
    [J]. BIPOLAR DISORDERS, 2016, 18 : 64 - 64
  • [7] Naltrexone augmented with prazosin for alcohol use disorder: results from a randomized controlled proof-of-concept trial
    Simpson, Tracy L.
    Achtmeyer, Carol
    Batten, Lisa
    Reoux, Joseph
    Shofer, Jane
    Peskind, Elaine R.
    Saxon, Andrew J.
    Raskind, Murray A.
    [J]. ALCOHOL AND ALCOHOLISM, 2024, 59 (05):
  • [8] Nonconvulsive Electrotherapy for Treatment Resistant Unipolar and Bipolar Major Depressive Disorder: A Proof-of-concept Trial
    Regenold, William T.
    Noorani, Robert J.
    Piez, Deborah
    Patel, Palak
    [J]. BRAIN STIMULATION, 2015, 8 (05) : 855 - 861
  • [9] Blame-rebalance fMRI neurofeedback in major depressive disorder: A randomised proof-of-concept trial
    Zahn, Roland
    Weingartner, Julie H.
    Basilio, Rodrigo
    Bado, Patricia
    Mattos, Paulo
    Sato, Joao R.
    de Oliveira-Souza, Ricardo
    Fontenelle, Leo F.
    Young, Allan H.
    Moll, Jorge
    [J]. NEUROIMAGE-CLINICAL, 2019, 24
  • [10] Trigeminal Nerve Stimulation (TNS) for Major Depressive Disorder in the Elderly: An Open Label Proof-of-Concept Trial
    Trevizol, Alisson Paulino
    Shiozawa, Pedro
    Cook, Ian A.
    Sato, Isa Albuquerque
    de Oliveira Diniz, Breno Satler
    Lowenthal, Rosane
    Barros, Mirna Duarte
    Cordeiro, Quirino
    [J]. BRAIN STIMULATION, 2016, 9 (01) : 146 - 147